These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35124531)

  • 1. Design and synthesis of pyrido[2,3-d]pyrimidine derivatives for a novel PAC1 receptor antagonist.
    Takasaki I; Watanabe A; Okada T; Kanayama D; Nagashima R; Shudo M; Shimodaira A; Nunomura K; Lin B; Watanabe Y; Gouda H; Miyata A; Kurihara T; Toyooka N
    Eur J Med Chem; 2022 Mar; 231():114160. PubMed ID: 35124531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of a novel and potent small-molecule antagonist of PAC1 receptor for the treatment of neuropathic pain.
    Takasaki I; Ogashi H; Okada T; Shimodaira A; Hayakawa D; Watanabe A; Miyata A; Kurihara T; Gouda H; Toyooka N
    Eur J Med Chem; 2020 Jan; 186():111902. PubMed ID: 31771828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Silico Screening Identified Novel Small-molecule Antagonists of PAC1 Receptor.
    Takasaki I; Watanabe A; Yokai M; Watanabe Y; Hayakawa D; Nagashima R; Fukuchi M; Okada T; Toyooka N; Miyata A; Gouda H; Kurihara T
    J Pharmacol Exp Ther; 2018 Apr; 365(1):1-8. PubMed ID: 29363578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal astrocytic activation contributes to both induction and maintenance of pituitary adenylate cyclase-activating polypeptide type 1 receptor-induced long-lasting mechanical allodynia in mice.
    Yokai M; Kurihara T; Miyata A
    Mol Pain; 2016; 12():. PubMed ID: 27175011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal Astrocyte-Neuron Lactate Shuttle Contributes to the Pituitary Adenylate Cyclase-Activating Polypeptide/PAC1 Receptor-Induced Nociceptive Behaviors in Mice.
    Kambe Y; Youkai M; Hashiguchi K; Sameshima Y; Takasaki I; Miyata A; Kurihara T
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central pituitary adenylate cyclase 1 receptors modulate nociceptive behaviors in both inflammatory and neuropathic pain states.
    Davis-Taber R; Baker S; Lehto SG; Zhong C; Surowy CS; Faltynek CR; Scott VE; Honore P
    J Pain; 2008 May; 9(5):449-56. PubMed ID: 18337184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice.
    Sándor K; Bölcskei K; McDougall JJ; Schuelert N; Reglodi D; Elekes K; Petho G; Pintér E; Szolcsányi J; Helyes Z
    Pain; 2009 Jan; 141(1-2):143-50. PubMed ID: 19091468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAC1 receptors mediate pituitary adenylate cyclase-activating polypeptide- and progesterone-facilitated receptivity in female rats.
    Apostolakis EM; Riherd DN; O'Malley BW
    Mol Endocrinol; 2005 Nov; 19(11):2798-811. PubMed ID: 15976009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired nocifensive behaviours and mechanical hyperalgesia, but enhanced thermal allodynia in pituitary adenylate cyclase-activating polypeptide deficient mice.
    Sándor K; Kormos V; Botz B; Imreh A; Bölcskei K; Gaszner B; Markovics A; Szolcsányi J; Shintani N; Hashimoto H; Baba A; Reglodi D; Helyes Z
    Neuropeptides; 2010 Oct; 44(5):363-71. PubMed ID: 20621353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel small-molecule antagonist of PAC1 receptor attenuates formalin-induced inflammatory pain behaviors in mice.
    Takasaki I; Nakamura K; Shimodaira A; Watanabe A; Du Nguyen H; Okada T; Toyooka N; Miyata A; Kurihara T
    J Pharmacol Sci; 2019 Feb; 139(2):129-132. PubMed ID: 30552012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel splice variants of type I pituitary adenylate cyclase-activating polypeptide receptor in frog exhibit altered adenylate cyclase stimulation and differential relative abundance.
    Alexandre D; Vaudry H; Grumolato L; Turquier V; Fournier A; Jégou S; Anouar Y
    Endocrinology; 2002 Jul; 143(7):2680-92. PubMed ID: 12072402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAC1 receptor antagonism in the bed nucleus of the stria terminalis (BNST) attenuates the endocrine and behavioral consequences of chronic stress.
    Roman CW; Lezak KR; Hartsock MJ; Falls WA; Braas KM; Howard AB; Hammack SE; May V
    Psychoneuroendocrinology; 2014 Sep; 47():151-65. PubMed ID: 25001965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
    Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired somatodendritic responses to pituitary adenylate cyclase-activating polypeptide (PACAP) of supraoptic neurones in PACAP type I -receptor deficient mice.
    Jamen F; Alonso G; Shibuya I; Widmer H; Vacher CM; Calas A; Bockaert J; Brabet P; Dayanithi G
    J Neuroendocrinol; 2003 Sep; 15(9):871-81. PubMed ID: 12899682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Src family kinase inhibitors blunt PACAP-induced PAC1 receptor endocytosis, phosphorylation of ERK, and the increase in cardiac neuron excitability.
    Tompkins JD; Clason TA; Buttolph TR; Girard BM; Linden AK; Hardwick JC; Merriam LA; May V; Parsons RL
    Am J Physiol Cell Physiol; 2018 Feb; 314(2):C233-C241. PubMed ID: 29141923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and messenger ribonucleic acid distribution of a cloned pituitary adenylate cyclase-activating polypeptide type I receptor in the frog Xenopus laevis brain.
    Hu Z; Lelievre V; Chao A; Zhou X; Waschek JA
    Endocrinology; 2000 Feb; 141(2):657-65. PubMed ID: 10650947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule non-peptide antagonists of the PACAP receptor attenuate acute restraint stress-induced anxiety-like behaviors in mice.
    Shintani Y; Yamano Y; Kuta M; Takeshita R; Takuma K; Okada T; Toyooka N; Takasaki I; Miyata A; Kurihara T; Hashimoto H; Hayata-Takano A
    Biochem Biophys Res Commun; 2022 Nov; 631():146-151. PubMed ID: 36194909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of AMPA receptor-mediated ion current by pituitary adenylate cyclase-activating polypeptide (PACAP) in CA1 pyramidal neurons from rat hippocampus.
    Costa L; Santangelo F; Li Volsi G; Ciranna L
    Hippocampus; 2009 Jan; 19(1):99-109. PubMed ID: 18727050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary adenylate cyclase-activating polypeptide stimulates renin secretion via activation of PAC1 receptors.
    Hautmann M; Friis UG; Desch M; Todorov V; Castrop H; Segerer F; Otto C; Schütz G; Schweda F
    J Am Soc Nephrol; 2007 Apr; 18(4):1150-6. PubMed ID: 17360952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenylate cyclase-activating polypeptide type 1 receptor signaling evokes long-lasting nociceptive behaviors through the activation of spinal astrocytes in mice.
    Ohnou T; Yokai M; Kurihara T; Hasegawa-Moriyama M; Shimizu T; Inoue K; Kambe Y; Kanmura Y; Miyata A
    J Pharmacol Sci; 2016 Apr; 130(4):194-203. PubMed ID: 26948958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.